Motor Neurone Disease Trial, Recruiting NCT06609213 Sponsor: Andrea Charvet Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT06609213
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed by their neurologist with possible, probable, or definite ALS (also called motor neuron disease), based on a specific set of medical criteria.
  • People who are already planning to have a feeding tube placed within the next 4 to 6 weeks.

Who may not be able to join:

  • People who have a history of Crohn's disease, inflammatory bowel disease, irritable bowel syndrome, coeliac disease, food allergies or sensitivities to any ingredients in the study formula, a neurodegenerative disease other than ALS, or any other ongoing condition that could cause gut or digestive symptoms.
  • People who have been diagnosed with frontotemporal dementia (a type of dementia that can affect behaviour and language).
  • People who are currently unable to eat or drink anything by mouth at all.
  • People who need a feeding tube placed urgently right away — for example, because of severe malnutrition or another immediate medical reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 954-262-6901

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Andrea Charvet
Registry
ClinicalTrials.gov
Start date
10 January 2025
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Gastrointestinal Symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov